论文部分内容阅读
质子泵抑制剂类(PPIs)药物是在治疗消化不良和胃食管反流病时最常使用的药物之一,能帮助抑制胃酸并帮助巴氏食道症患者预防食管癌,但是香港大学的一项新研究发现,这类药物可能会增加患者患胃癌的风险。研究人员表示,质子泵抑制剂类药物可能将患者患胃癌的概率增加至原来的2~8倍——连续服药超过1年可将患者患胃癌的风险增加至原来的5倍,连续服药2~3年的患者患胃癌的风险为原来的6倍,连续服药3年及以上的患者患胃癌的风险为原来的8
Proton pump inhibitors (PPIs), one of the most commonly used drugs in the treatment of dyspepsia and gastroesophageal reflux disease, help to inhibit stomach acid and help prevent esophageal cancer in patients with PAS, but a Hong Kong University The new study found that such drugs may increase the risk of gastric cancer in patients. The researchers said that proton pump inhibitors may increase their chance of developing gastric cancer by 2 to 8 times - taking more than 1 year of continuous medication may increase the risk of developing gastric cancer by up to 5 times, taking 2 - Three years of patients with gastric cancer risk was 6 times the original, three consecutive years of medication and above patients with gastric cancer risk of the original 8